FDA rejects biotech co.’s non-Hodgkin’s lymphoma treatment Biogen Idec, Acorda Therapeutics to develop, commercialize MS drug BioSante, Cell Genesys to merge Bayer, Celera to develop cancer drugs Merck KGaA launches RebiSmart Takeda completes acquisition of IDM Pharma Active ingredient in eye drug may work as hair loss treatment GSK completes acquisition of Stiefel First Previous 234 235 236 237 238 Next Last